Gallagher, C.J.; Bowsher, R.R.; Clancy, A.; Dover, J.S.; Humphrey, S.; Liu, Y.; Prawdzik, G.
Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials. Toxins 2023, 15, 60.
https://doi.org/10.3390/toxins15010060
AMA Style
Gallagher CJ, Bowsher RR, Clancy A, Dover JS, Humphrey S, Liu Y, Prawdzik G.
Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials. Toxins. 2023; 15(1):60.
https://doi.org/10.3390/toxins15010060
Chicago/Turabian Style
Gallagher, Conor J., Ronald R. Bowsher, Amanda Clancy, Jeffrey S. Dover, Shannon Humphrey, Yan Liu, and Gregg Prawdzik.
2023. "Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials" Toxins 15, no. 1: 60.
https://doi.org/10.3390/toxins15010060
APA Style
Gallagher, C. J., Bowsher, R. R., Clancy, A., Dover, J. S., Humphrey, S., Liu, Y., & Prawdzik, G.
(2023). Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials. Toxins, 15(1), 60.
https://doi.org/10.3390/toxins15010060